163 related articles for article (PubMed ID: 31428834)
1. Largely Unchanged Annual Incidence and Overall Survival of Pleural Mesothelioma in the USA.
Keshava HB; Tang A; Siddiqui HU; Raja S; Raymond DP; Bribriesco A; Stevenson J; Murthy SC; Ahmad U
World J Surg; 2019 Dec; 43(12):3239-3247. PubMed ID: 31428834
[TBL] [Abstract][Full Text] [Related]
2. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients.
Taioli E; Wolf AS; Camacho-Rivera M; Kaufman A; Lee DS; Nicastri D; Rosenzweig K; Flores RM
PLoS One; 2015; 10(12):e0145039. PubMed ID: 26660351
[TBL] [Abstract][Full Text] [Related]
3. Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009.
Soeberg MJ; Leigh J; Driscoll T; Armstrong B; Young JM; van Zandwijk N
Occup Environ Med; 2016 Mar; 73(3):187-94. PubMed ID: 26800709
[TBL] [Abstract][Full Text] [Related]
4. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.
Beckett P; Edwards J; Fennell D; Hubbard R; Woolhouse I; Peake MD
Lung Cancer; 2015 Jun; 88(3):344-8. PubMed ID: 25863904
[TBL] [Abstract][Full Text] [Related]
5. Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.
Damhuis RA; Khakwani A; De Schutter H; Rich AL; Burgers JA; van Meerbeeck JP
Lung Cancer; 2015 Aug; 89(2):212-7. PubMed ID: 26044908
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database.
Bou-Samra P; Chang A; Azari F; Kennedy G; Segil A; Guo E; Marmarelis M; Langer C; Singhal S
Cancer Med; 2023 Jun; 12(11):12208-12220. PubMed ID: 37062067
[TBL] [Abstract][Full Text] [Related]
7. Pediatric, Adolescent and Young Adult (AYA) Peritoneal and Pleural Mesothelioma: A National Cancer Database Review.
Nofi CP; Roberts BK; Rich BS; Glick RD
J Pediatr Surg; 2024 Jun; 59(6):1113-1120. PubMed ID: 38418273
[TBL] [Abstract][Full Text] [Related]
8. Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.
Nelson DB; Rice DC; Niu J; Atay SM; Vaporciyan AA; Antonoff MB; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Tsao AS; Gomez DR; Giordano SH; Mehran RJ; Sepesi B
Eur J Cardiothorac Surg; 2018 May; 53(5):960-966. PubMed ID: 29211849
[TBL] [Abstract][Full Text] [Related]
9. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W
Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of malignant pleural mesothelioma in the province of Sassari (Sardinia, Italy). A population-based report.
Budroni M; Cossu A; Paliogiannis P; Palmieri G; Attene F; Cesaraccio R; Tanda F
Ann Ital Chir; 2014; 85(3):244-8. PubMed ID: 23899648
[TBL] [Abstract][Full Text] [Related]
11. Ambient Asbestos Fiber Concentrations and Long-Term Trends in Pleural Mesothelioma Incidence between Urban and Rural Areas in the United States (1973-2012).
Glynn ME; Keeton KA; Gaffney SH; Sahmel J
Risk Anal; 2018 Mar; 38(3):454-471. PubMed ID: 28863229
[TBL] [Abstract][Full Text] [Related]
12. Letter to the Editor: Largely Unchanged Annual Incidence and Overall Survival of Pleural Mesothelioma in the USA.
Lauer DJ; Mundt KA; Thompson WJ; Best EA
World J Surg; 2020 Dec; 44(12):4279-4280. PubMed ID: 32808074
[No Abstract] [Full Text] [Related]
13. Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.
Lin RT; Chang YY; Wang JD; Lee LJ
J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):463-470. PubMed ID: 30072200
[TBL] [Abstract][Full Text] [Related]
14. National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.
Saddoughi SA; Abdelsattar ZM; Blackmon SH
Ann Thorac Surg; 2018 Feb; 105(2):432-437. PubMed ID: 29223422
[TBL] [Abstract][Full Text] [Related]
15. Macroscopic complete resection is not associated with improved survival in patients with malignant pleural mesothelioma.
Batirel HF; Metintas M; Caglar HB; Ak G; Yumuk PF; Ahiskali R; Bozkurtlar E; Bekiroglu N; Lacin T; Yildizeli B; Yuksel M
J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2724-2733. PubMed ID: 29510939
[TBL] [Abstract][Full Text] [Related]
16. Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study.
de Boer NL; van Kooten JP; Damhuis RAM; Aerts JGJV; Verhoef C; Madsen EVE
Ann Surg Oncol; 2019 Dec; 26(13):4222-4228. PubMed ID: 31620941
[TBL] [Abstract][Full Text] [Related]
17. Malignant pleural mesothelioma characteristics and outcomes: A SEER-Medicare analysis.
Taioli E; Wolf A; Alpert N; Rosenthal D; Flores R
J Surg Oncol; 2023 Jul; 128(1):134-141. PubMed ID: 36932968
[TBL] [Abstract][Full Text] [Related]
18. Longevity and pleural mesothelioma: age-period-cohort analysis of incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program, 1973-2013.
Kerger BD
BMC Res Notes; 2018 May; 11(1):337. PubMed ID: 29792222
[TBL] [Abstract][Full Text] [Related]
19. Increased mesothelioma incidence in New Zealand: the asbestos-cancer epidemic has started.
Kjellstrom T; Smartt P
N Z Med J; 2000 Nov; 113(1122):485-90. PubMed ID: 11198540
[TBL] [Abstract][Full Text] [Related]
20. [Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival].
Desoubeaux N; Bouvier V; Gervais R; Galateau-Salle F; Thibon P; Leplumey T; Herbert C; Lecherbonnier Y; Daviet JP; Letourneux M
Rev Epidemiol Sante Publique; 2001 Dec; 49(6):523-9. PubMed ID: 11845101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]